3月4日 - ** 总部位于新泽西州的 药品分销商Wellgistics Health WGRX.O股价盘前上涨9.3%至2.95美元
** 公司宣布正在与 Protega Pharmaceuticals 合作 (link)，以增加患者获得 Protega 的阿片类药物 Roxybond 的机会
** Roxybond 适用于在其他治疗方法效果不佳的情况下控制剧烈疼痛
** WGRX 自 2 月 21 日上市以来已下跌 29
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.